Galapagos (GLPG) Competitors

Galapagos (NASDAQ:GLPG) and TG Therapeutics (NASDAQ:TGTX) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, earnings, profitability, community ranking, dividends, risk, institutional ownership, media sentiment and analyst recommendations.

Does the MarketBeat Community prefer GLPG or TGTX?

TG Therapeutics received 193 more outperform votes than Galapagos when rated by MarketBeat users. Likewise, 76.27% of users gave TG Therapeutics an outperform vote while only 63.84% of users gave Galapagos an outperform vote.

Company	Underperform	Outperform
Galapagos	Outperform Votes 466 63.84%	Underperform Votes 264 36.16%
TG Therapeutics	Outperform Votes 659 76.27%	Underperform Votes 205 23.73%

Is GLPG or TGTX more profitable?

Galapagos has a net margin of 0.00% compared to TG Therapeutics' net margin of -5.42%. Galapagos' return on equity of 0.00% beat TG Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Galapagos	N/A	N/A	N/A
TG Therapeutics	-5.42%	-8.32%	-3.40%

Do analysts prefer GLPG or TGTX?

Galapagos currently has a consensus price target of $25.33, suggesting a potential upside of 4.68%. TG Therapeutics has a consensus price target of $40.67, suggesting a potential upside of 5.88%. Given TG Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe TG Therapeutics is more favorable than Galapagos.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Galapagos	4 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
TG Therapeutics	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

Does the media refer more to GLPG or TGTX?

In the previous week, TG Therapeutics had 8 more articles in the media than Galapagos. MarketBeat recorded 15 mentions for TG Therapeutics and 7 mentions for Galapagos. Galapagos' average media sentiment score of 1.27 beat TG Therapeutics' score of 1.21 indicating that Galapagos is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Galapagos	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
TG Therapeutics	10 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has stronger earnings & valuation, GLPG or TGTX?

Galapagos has higher earnings, but lower revenue than TG Therapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Galapagos	$275.65M	5.79	$80.16M	N/A	N/A
TG Therapeutics	$329.00M	18.34	$12.67M	$0.14	274.36

Do institutionals & insiders hold more shares of GLPG or TGTX?

32.5% of Galapagos shares are held by institutional investors. Comparatively, 58.6% of TG Therapeutics shares are held by institutional investors. 2.9% of Galapagos shares are held by insiders. Comparatively, 10.5% of TG Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Which has more volatility & risk, GLPG or TGTX?

Galapagos has a beta of 0.16, suggesting that its share price is 84% less volatile than the S&P 500. Comparatively, TG Therapeutics has a beta of 2.14, suggesting that its share price is 114% more volatile than the S&P 500.

Summary

TG Therapeutics beats Galapagos on 11 of the 16 factors compared between the two stocks.